For citations:
Rudakova A.V. PHARMACOECONOMICS OF ORAL PARICALCITOL THERAPY IN PATIENTS WITH A CHRONIC KIDNEY DISEASE AND SECONDARY HYPERPARATHYROIDISM. Nephrology (Saint-Petersburg). 2019;23(1):67-72. (In Russ.) https://doi.org/10.24884/1561-6274-2019-23-1-67-72